The OP article provides clear evidence that for-profit companies is not limited to Pharma: > ...insurers, chemists, drug distributors and pharmacy-benefit mana

The OP article provides clear evidence that for-profit companies is not limited to Pharma: > ...insurers, chemists, drug distributors and pharmacy-benefit managers (PBMs)—sitting between patients and their treatments. In 2022 the combined revenue of the nine biggest middlemen—call them big health—equated to nearly 45% of America’s health-care bill, up from 25% in 2013. Big health accounts for eight of the top 25 companies by revenue in the S&P 500 index of America’s leading stocks, compared with four for big tech and none for big pharma. It goes on to detail their profit relative to the S&P as well.